TLRY - ティルレイ (Tilray Inc.) ティルレイ

 TLRYのチャート


 TLRYの企業情報

symbol TLRY
会社名 Tilray Inc (ティルレイ)
分野(sector) Consumer Durables   耐久消費財
産業(industry) Specialty Chemicals  
業種 医薬品   医療関連(Health Care)
概要 事業概要 ティルレイ(Tilray Inc)は医薬品分野に従事するカナダを拠点とする企業である。同社はカンナビス製品を医薬品販売業者に供給する。同社は医療カンナビスの研究、栽培、加工および世界中のカンナビス製品の販売に焦点を当てる。また、オーストラリア、カナダ、ドイツの子会社を通じて5大陸にまたがる多数の国の患者にカンナビス製品を供給し、カナダおよびヨーロッパで医療用カンナビスを生産する。   ティルレイはカナダ医薬品企業。主に医療用大麻の製造・販売に従事する。同社は大麻に含まれる化学物質カンナビノイドをベ―スとする医薬品を、カナダ国内およびアルゼンチン、オ―ストラリア、チリ、クロアチア、キプロス、チェコ、ドイツ、ニュ―ジ―ランド、南アフリカにおいて販売する。本社所在地はブリティッシュ・コロンビア。   Tilray is a global pioneer in the research, cultivation, production, and distribution of cannabis and cannabinoids currently serving tens of thousands of patients and consumers in 17 countries spanning five continents.
本社所在地 1100 Maughan Road Nanaimo British Columbia V9X IJ2 CAN
代表者氏名
代表者役職名
電話番号 +1 416-934-2141
設立年月日 43101
市場名 NASDAQ National Market System
ipoyear 2018年
従業員数 330人
url www.tilray.com
nasdaq_url https://www.nasdaq.com/symbol/tlry
adr_tso
EBITDA EBITDA(百万ドル) -17.20800
終値(lastsale) 139.77
時価総額(marketcap) 13018742750.34
時価総額 時価総額(百万ドル) 12290.36
売上高 売上高(百万ドル) 28.07100
企業価値(EV) 企業価値(EV)(百万ドル) 12319.77
当期純利益 当期純利益(百万ドル) -22.69000
決算概要 決算概要 BRIEF: For the six months ended 30 June 2018 Tilray Inc revenues increased 75% to $17.6M. Net loss increased from $3.1M to $18M. Revenues reflect Canada (Country) segment increase from $5M to $17M other countries segment increase from $0K to $540K. Higher net loss reflects General and administrative expenses - Ba increase from $3.9M to $10M (expense) Stock-based compensation expense increase from $69K to $5.6M (expense).

 TLRYのテクニカル分析


 TLRYのニュース

   Stocks Slumber to End Week  2022/06/03 20:23:00 Baystreet Canada
Equities in Canada’s largest centre endured a sharply negative end to a wild week, as lower prices for health-care and tech issues cast a pall over the indexes. The S&P/TSX lost 241.08 points, or 1.2%, to close Friday and the week at 20,790.73. Over the last five session, the index moved forward, however, 42 points, or 0.2%. The Canadian dollar dipped 0.13 cents to 79.42 cents U.S. Tech stocks provided the heaviest weight on the market, with Shopify plunging $59.97, or 12%, to $441.17, while Magnet Forensics stumbled $1.03, or 6.3%, to $15.46. Cannabis concerns proved the main agent of the demise, as Canopy Growth flopped 49 cents, or 8,3%, to $5.43, while rival Tilray faltered 29 cents, or 8.3%, to $5.29. In consumer discretionary stocks, BRP lost $10.79, or 10.7%, to $89.79, while Martinrea International subsided 81 cents, or 7.9%, to $9.45. Consumer staples tried to even things out, with Loblaw jumping $1.98, or 1.7%, to $117.66, while Metro advanced 78 cents, or 1.1%, to $71.59. Energy stocks also muscled up, with Baytex taking on 53 cents, or 7.6%, to $7.63, while Tamarack Valley gained 27 cents, or 5.1%, to $5.62.
   TSX Steps Back from Thursday Gains  2022/06/03 16:16:00 Baystreet Canada
Stocks in Canada’s main market were driven lower on Friday as upbeat U.S. jobs data deepened concerns of more interest rate hikes. The S&P/TSX had lost 216.74 points, or 1%, by noon to 20,815.07. The Canadian dollar dipped 0.03 cents to 79.52 cents U.S. Cannabis concerns proved the main agent of the demise, as Canopy Growth flopped 41 cents, or 6.9%, to $5.51, while rival Tilray faltered 30 cents, or 5.4%, to $5.28. In tech stocks, Docebo fell $2.74, or 6.3%, to $40.81, while Shopify stumbled $45.48, or 9.1%, to $455.66. In gold stocks, Alamos Gold dulled in price 51 cents, or 4.8%, to $10.09, while IAMGOLD Corporation demurred 12 cents, or 4%, to $2.90. ON BAYSTREET The TSX Venture Exchange lurched lower 8.51 points, or 1.2%, to 719.96. All 12 TSX subgroups were down midday, as health-care subsided 3.3%, information technology slouched 3.1%, and gold dropped 2.2%. ON WALLSTREET U.S. stocks slid Friday as investors digested a stronger-than-expected jobs report and its implication for monetary policy going forward.
   Flora Growth Follows Tilray: Reaches Amazon UK With Its Cannabis Brand JustCBD  2022/05/31 12:24:25 Benzinga
JustCBD wholly-owned subsidiary of Flora Growth Corp. (NASDAQ: FLGC ) will be launching its line of n ovel f oods registered CBD products on Amazon.co.uk. The news comes on the heels of Canadian cannabis giant, Tilray (NASDAQ: TLRY ) rolling out its CBD lifestyle brand with a new approach to wellness, POLLEN, on the same online retail platform. Amazon UK (NASDAQ: AMZN ) entered the now £700 million CBD market in October 2021 and has since expanded the initial pilot-only program to include vendors who have demonstrated their … Full story available on Benzinga.com
   Want to Invest in Pot Stocks? Buy Tilray, Not HEXO  2022/05/30 11:09:43 InvestorPlace
Source: Shutterstock Cannabis stocks have experienced significant growth in the past few months. However, this trend came to an end in the last few weeks when the stocks of many cannabis companies started to plummet. Unfortunately, HEXO (NASDAQ: HEXO ) stock is not an exception in this regard. Following a string of unfortunate events, the Canadian cannabis producer is in rough shape. The past year has been tough for them, not least because of the audit firm PricewaterhouseCoopers warning that the company’s debt situation is raising concerns about its “going concern” status. After a long string of bad luck and setbacks, the company recently found a new opportunity. Tilray (NASDAQ: TLRY ) expressed interest in purchasing some of their debt to help save the company — even though everyone is still on edge about how the buyout will affect them. In March, Tilray agreed to purchase up to $211 million in HEXO’s debt, giving Tilray the right to buy a significant portion of HEXO. HEXO has been facing financial turmoil, so the new deal helped perk up investor sentiment.
   Cannabis Stocks ACB, CGC, TLRY Fall as Earnings Disappoint  2022/05/27 14:17:44 InvestorPlace
Source: Jetacom Autofocus / Shutterstock.com Many cannabis stocks are declining today after one of the largest companies in the sector, Canopy Growth (NASDAQ: CGC ), reported fiscal fourth-quarter results that were significantly below analysts’ average estimates. CGC stock is tumbling 15% in early trading. Meanwhile, another cannabis company, Aurora (NASDAQ: ACB ), announced that it would raise $150 million by selling stock and warrants. That news also seems to be putting downward pressure on cannabis stocks. Canopy’s Q4 Results The company’s Q4 revenue dropped 25% to 111.8 million CAD, well below analysts’ average estimate of 130.5 million CAD. The cannabis maker reported a per share loss of 1.46 Canadian dollars. That is also much wider than estimates for a loss of 21 cents CAD. Canopy CFO Judy Hong said: “Achieving profitability is critical and we have undertaken additional initiatives to streamline and drive efficiencies for our global cannabis business. … [W]e are focused on executing our path to profitability in Canada, while we continue to invest in high potential opportunities.” The company added that it would seek to grow its business in the U.S.
   A Look Into Tilray''s Debt  2022/01/06 13:44:58 Benzinga
Over the past three months, shares of Tilray (NASDAQ: TLRY ) fell by 35.12%. Before we understand the importance of debt, let us look at how much debt Tilray has. Tilray''s Debt According to the Tilray''s most recent balance sheet as reported on October 7, 2021, total debt is at $816.60 million, with $776.56 million in long-term debt and $40.04 million in current debt. Adjusting for $376.30 million in cash-equivalents, the company has a net debt of $440.30 million. Let''s define some of the terms we used in the paragraph above. Current debt is the portion of a company''s debt which is due within 1 year, while long-term debt Full story available on Benzinga.com
   Tilray Continues To Slide Lower; Is A Bounce To Higher Prices In Sight?  2022/01/05 19:40:37 Benzinga
Tilray Inc. (NASDAQ: TLRY ) shares are trading lower Wednesday as the cannabis sector declines as a whole. The stock has recently fallen below support in what traders call a sideways channel and appears to be dropping further from the support level. The stock was trending throughout the day on social media sites such as StockTwits. Tilray was down 5.06% to $6.75 at the time of publication. See Related: These 2 Cannabis Stocks Were Among The Most Searched Benzinga Tickers In 2021: Here''s Why Tilray Daily Chart Analysis The stock was trading in a sideways channel before falling below the $10 Full story available on Benzinga.com
   Tilray stock forecast: can TLRY stock recover from an 88% drop?  2021/12/22 09:30:43 Capital Com
Tilray has plummeted over 88% since February, could a recovery be on the cards? Read on for analysts projections and the latest Tilray share price forecast. Read More
   Todays Hot Mover: Tilray, Inc. (NASDAQ:TLRY), XPeng Inc. (NYSE:XPEV)  2021/12/22 09:20:18 Stock Equity
Tilray, Inc. (NASDAQ:TLRY) with the stream of 5.23% also noticed, India XPeng Inc. (NYSE:XPEV) encountered a rapid change of 10.98% in the last hour of Tuesdays trading session. Tilray, Inc. The post Todays Hot Mover: Tilray, Inc. (NASDAQ:TLRY), XPeng Inc. (NYSE:XPEV) appeared first on Stocks Equity .
   Tilray, Inc. (TLRY) to Announce Second Quarter Fiscal 2022 Financial Results on January 10, 2022  2021/12/20 14:04:19 Marijuana Stocks
Tilray to Announce Second Quarter Fiscal 2022 Financial Results on January 10,
   Enslaving stocks: Tilray, Inc. (NASDAQ:TLRY -2.02%), Freeport-McMoRan Inc. (NYSE:FCX 0.19%)  2021/09/03 22:05:35 Stock Equity
There are two main reasons why moving averages are useful in forex trading: moving averages help traders define trend recognize changes in trend. Now well have a look on, SMA50 The post Enslaving stocks: Tilray, Inc. (NASDAQ:TLRY -2.02%), Freeport-McMoRan Inc. (NYSE:FCX 0.19%) appeared first on Stocks Equity .
   Tilray stock forecast: can TLRY recover after 80% losses?  2021/09/03 16:00:00 Capital Com
Shares in the Canadian firm have plummeted dramatically so far in 2021. What does that mean for the Tilray share price forecast? Read on to find out. Read More
   Timber Point Global Allocations Fund Buys iShares 20+ Year Treasury Bond ETF, iShares Gold ...  2021/08/31 22:38:02 GuruFocus
Related Stocks: SWBI , BA , NNDM , OTRK , HCDI , TLT , IAU , AAPL , AMZN , PHO , TLRY , XLI , KRE , RVT , TLRY , TLRY , XLI ,
   Why Tilray''s Stock Looks Like It''s Beginning To Reverse  2021/08/31 21:28:21 Benzinga
Tilray Inc (NASDAQ: TLRY ) shares are trading higher Tuesday, moving alongside other popular cannabis names. The overall sector is moving higher as continued optimism on cannabis legalization is possibly a factor. Tilray was up 4.27% at $13.69 at last check Tuesday afternoon. Tilray Daily Chart Analysis Shares have been falling and look like they could be ready to start turning around if they are able to break out of what technical traders call a falling wedge pattern. The stock has been getting condensed between narrowing highs and lows and is now nearing the point Full story available on Benzinga.com
   Cannabis Stocks: Why Are ACB, CGC, TLRY, SNDL Stocks Turning Green Today?  2021/08/31 19:56:50 InvestorPlace
InvestorPlace - Stock Market News, Stock Advice & Trading Tips Here''s what investors are watching today in the cannabis sector, as a host of the most popular cannabis stocks take off. The post Cannabis Stocks: Why Are ACB, CGC, TLRY, SNDL Stocks Turning Green Today? appeared first on InvestorPlace . More From InvestorPlace Stock Prodigy Who Found NIO at $2 Says Buy THIS Now Analyst Who Found Microsoft at $0.38 Names #1 Pick for the AI Boom Americas #1 EV Stock Still Flying Under the Radar

 関連キーワード  (医薬品 米国株 ティルレイ TLRY Tilray Inc.)

 twitter  (公式ツイッターやCEOツイッターなど)